Massachusetts Society of Clinical Oncologists - The Centers for Medicare and Medicaid Services (CMS) Assign a Permanent J-Code for Polivy (polatuzumab vedotin-piiq)

"The voice for cancer physicians and their patients in Massachusetts."

Home
Resources
Protocols Listing
The Centers for Medicare and Medicaid Services (CMS) Assign a Permanent J-Code for Polivy (polatuzumab vedotin-piiq)

The Centers for Medicare and Medicaid Services (CMS) Assign a Permanent J-Code for Polivy (polatuzumab vedotin-piiq)

16 Dec 2019 2:01 PM | Nathan Strunk

The Centers for Medicare and Medicaid Services (CMS) has assigned a permanent J-code for Polivy (polatuzumab vedotin-piiq; Genentech). Effective January 1, 2020, the J-code is J9309 (Injection, polatuzumab vedotin-piiq, 1 mg).

Massachusetts Society of Clinical Oncologists (c)

P.O. Box 549154, Waltham, MA, 02451
t: 781.434.7329 | f: 781.464.4896 |email: msco@mms.org